Ardent Health announces definitive agreement to acquire Boone Health

Ardent Health, Inc. (ARDT) filed an SEC Form 8-K — Regulation FD Disclosure. EXHIBIT 99 Ardent Health announces definitive agreement to acquire Boone Health • Expands Ardent’s footprint into an attractive mid-sized Missouri market with a scaled health system that generates ~$480 million of annual revenue 1 • Provides $200 million capital commitment over 1

Event · M&A · definitive agreement
Role
acquirer
Counterparty
Boone Health
Deal value
$47 million
Consideration
cash
Expected close
first quarter of 2027

Facts are quoted from the filing text and checked against it.

Original reporting
Published Nov 12, 2026, 9:16 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 12, 2026, 9:19 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefMergers & acquisitions
Primary signal
$ARDT
Bullish
high confidence
Mentioned
$ARDT
Relevance
7/10
AlphAI data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$ARDTBullishHigh
01

Why it matters

The acquisition of Boone Health provides geographic expansion, revenue diversification, and synergies that are projected to boost EBITDA, supporting a positive stock reaction.

02

Market read

First‑report 8‑K disclosure of a $47 M cash acquisition with a $200 M capital commitment, expected to be accretive, creating immediate trading relevance for ARDT.

03

What to watch

The $200 million capital commitment could strain cash flow if not managed, and regulatory approvals may introduce delays.

Relevance 7/10Novelty 8/10Timing: today, with conference call at 5 p.m. ET

Background

Ardent Health is a publicly traded operator of community hospitals and outpatient facilities, seeking growth through strategic acquisitions.

Company-level read

Ticker impact

$ARDTBullishHigh confidence
Context

Ardent Health (NYSE: ARDT) disclosed a definitive agreement to acquire Boone Health for $47 million cash with a $200 million capital commitment over 10 years.

Expected impact

likely upward pressure as the market prices in the accretive M&A and long‑term capital commitment.

Evidence & confidence

Primary 8‑K filing provides new material information; the deal size and accretion forecast are material for a mid‑cap health operator.

Market effects

Adds to consolidation trend in regional health systems, may prompt peers to consider similar acquisitions.

Expands Ardent's footprint in the Midwest, potentially increasing competition for local providers.

Limited to U.S. healthcare sector; no broader macro impact.

Counterpoint

Deal size is modest and integration risk could weigh on margins; investors may wait for post‑close performance.

Key entities

  • Ardent Health, Inc.

    Acquirer, listed on NYSE under ARDT.

  • Boone Health

    Target, a not‑for‑profit health system in Columbia, Missouri.

Related articles

$ARDTMed

BofA raises Ardent Health stock price target on acquisition upside

BofA Securities raised its price target on Ardent Health Partners (ARDT) to $14 from $12, citing the company's acquisition of Boone Health. The stock trades at $17.68, near its 52-week high. BofA expects the deal to add $5M-$10M in EBITDA in the first year, growing to $30M-$40M by the third year. Ardent reported Q3 2026 earnings of $0.31 per share, beating estimates. Mizuho also raised its target to $21, maintaining an Outperform rating.

$ARDTMed

What Ardent Health (ARDT) Said on Its Q3 Earnings Call

Ardent Health (ARDT) reported Q3 earnings, highlighting a 9% increase in urgent care visits and a 400 basis point decline in physician referral leakage. Labor costs fell 4.3% YoY, and the company plans to sell a Kansas hospital for 11x EBITDA. Ardent generated $122M in Q3 operating cash flow and lowered its 2026 capital expenditure guidance. The company remains 85% contracted for 2027 and 75% for 2028, with negotiations described as contentious.

$ARDTHighAI 8/10

Ardent Health (ARDT) Q3 2026 Earnings Call Transcript

Ardent Health (ARDT) reported Q3 2026 adjusted EBITDA of $138M, up 1.5% from prior guidance. Revenue was $1.62B, with adjusted admissions up 2.9%. The company plans to divest a Kansas hospital at 11x EBITDA, enhancing margins by 40bps. Ardent's IMPACT program aims for $70M in savings this year, and it raised its EBITDA guidance midpoint by 1.5%.

$ARDTHigh

Ardent Health Reports Third Quarter 2026 Results

Ardent Health, Inc. (ARDT) filed an SEC Form 8-K — Results of Operations and Financial Condition. 1 Exhibit 99.1 Ardent Health Reports Third Quarter 2026 Results Brentwood, Tenn. ( November 4, 2026 ) – Ardent Health, Inc. (NYSE: ARDT) ("Ardent Health" or the "Company"), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced re